“…1), [CH 3 (CH 2 ) 17 ] 2 NCH 2 CH 2 CONHCH 2 CH 2 N(CH 2 CH 2 CONHCH 2 CH 2 NH 2 ) 2 (PD; modified from DL-G1 in [23], supplied by Katayama Chemical Industries, Japan), (2) 2,3-dioleyloxy-N-[2(sperminecarboxamido)ethyl]-n,n-dimethyl-1-propanaminium trifluoroacetate (DOSPA) and dioleoylphosphatidylethanolamine (DOPE) mixed at the mass ratio of 3: 1 (LF; Lipofectamine Ò , Life Technologies, USA), and (3) N-[1-(2,3-dioloyloxy) propyl]-N,N,N-trimethylammonium methylsulfate (DT; DOTAP, Roche, Switzerland). PD is a newly developed Lp [23][24][25], whereas LF and DT are conventional ones used in previous studies [19,20]. As a DNA source, pGL3 control vector (Promega, USA), which was propagated and purified in 0.7-1.2 mg/mL plasmid, was used.…”